ERBB2 and cancer: In a clinically relevant mice model of HER2-posititive cancer (the polyoma middle T oncoprotein transgenic mice, MMTV-neu mouse) selective overexpression of HER2 in the mammary epithelium resulted in the formation of focal tumors in the breast and lung metastases.